Factors influencing the choice of antidepressants: A study of antidepressant prescribing practice at University Psychiatric Clinic in Belgrade;Faktori koji utiču na izbor antidepresiva: Analiza propisivanja na Univerzitetskoj psihijatrijskoj klinici u Beogradu

Vojnosanitetski Pregled

Volumn 69, Issue 4, 2012, Pages 308-313

  Marić, Nadja P ^a,b   Stojiljković, Dragan J ^b   Pavlović, Zorana ^b   Jašović Gašić, Miroslava ^a,b  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b CLINICAL CENTER OF SERBIA   (Serbia)

Author keywords

Antidepressive agents; Drug prescriptions; Patients; Pharmaceutical preparations; Physicians

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CLOMIPRAMINE; ESCITALOPRAM; FLUOXETINE; MAPROTILINE; MIANSERIN; MIRTAZAPINE; MOCLOBEMIDE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TIANEPTINE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ADULT; ANXIETY DISORDER; ARTICLE; BIPOLAR DISORDER; CLINICAL COMPETENCE; CLINICAL PRACTICE; COMORBIDITY; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DEPRESSION; DEVELOPED COUNTRY; DISEASE DURATION; DISEASE SEVERITY; DRUG CHOICE; DRUG CLASSIFICATION; DRUG UTILIZATION; EDUCATIONAL STATUS; EMPLOYMENT STATUS; FEMALE; HEALTH ECONOMICS; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MARRIED MAN; MARRIED WOMAN; MEDICAL RECORD REVIEW; MONOTHERAPY; NATIONAL HEALTH INSURANCE; ORGANIC PSYCHOSYNDROME; PHARMACOEPIDEMIOLOGY; POLYPHARMACY; PRESCRIPTION; PSYCHIATRIST; PSYCHOSIS; RECOMMENDED DRUG DOSE; REIMBURSEMENT; RETROSPECTIVE STUDY; SERBIA; SEX DIFFERENCE; SUICIDE ATTEMPT;

ANTIDEPRESSIVE AGENTS; DRUG UTILIZATION; FEMALE; HUMANS; MALE; MENTAL DISORDERS; MIDDLE AGED; PSYCHIATRY;

EID: 84859197755     PISSN: 00428450     EISSN: None     Source Type: Journal    
DOI: 10.2298/VSP1204308M     Document Type: Article

References (17)

1. Sheehan DV, Keene MS, Eaddy M, Krulewicz S, Kraus JE, Carpenter DJ. Differences in medication adherence and healthcare resource utilization patterns: older versus newer antidepressant agents in patients with depression and/or anxiety disorders. CNS Drugs. 2008; 22(11): 963-73.
2. Divac N, Tosevski DL, Babić D, Djurić D, Prostran M, Samardzić R. Trends in consumption of psychiatric drugs in Serbia and Montenegro 2000-2004. Pharmacoepidemiol Drug Saf 2006; 15(11): 835-8.
3. Stahl S. Essential Psychopharmacology. The Presciber's Guide. Cambridge: Cambridge University Press; 2005.
4. Vucinić S. Risk factors for the development of pneumonia in acute psychotropic drugs poisoning. Vojnosanit Pregl 2005; 62(10): 715-23. (Serbian)
5. Divac N, Marić NP, Damjanović A, Jovanović AA, Jasović-Gasić M, Prostran M. Use or underuse of therapeutic guidelines in psychiatry? Psychiatr Danub 2009; 21(2): 224-9.
6. Paunovic VR. Terapheutical guidelines in treatment of depression. Beograd: CIBID; 2004. (Serbian)
7. Trivedi MH, Claassen CA, Grannemann BD, Kashner TM, Carmody TJ, Daly E, et al. Assessing physicians' use of treatment algorithms: Project IMPACTS study design and rationale. Contemp Clin Trials 2007; 28(2): 192-212.
8. Zimmerman M, Posternak M, Friedman M, Attiullah N, Baymiller S, Boland R, et al. Which factors influence psychiatrists' selection of antidepressants? Am J Psychiatry 2004; 161(7): 1285-9.
9. Sim K, Lee NB, Chua HC, Mahendran R, Fujii S, Yang SY, et al. Newer antidepressant drug use in East Asian psychiatric treatment settings: REAP (Research on East Asia Psychotropic Prescriptions) Study. Br J Clin Pharmacol 2007; 63(4): 431-7.
10. Bauer M, Monz BU, Montejo AL, Quail D, Dantchev N, Demyttenaere K, et al. Prescribing patterns of antidepressants in Europe: results from the Factors Influencing Depression Endpoints Research (FINDER) study. Eur Psychiatry 2008; 23(1): 66-73.
11. Lisulov R, Nedic A. The diagnostic and treatment problems in depressive disorders in the primary health care institutions in AP Vojvodini. Novi Sad: University of Novi Sad, Medical Faculty; 2006. (Serbian)
12. Jašović-Gašić M, Damjanovic A, Maric N, Miljevic C, Djuric D. Antidepressants. Vršac: Hemofarm; 2006. (Serbian)
13. Jašovic-Gašic M, Damjanovic A, Maric N, Miljevic C. Antidepressants-manuel for cinical practice. Niš: Studentski kulturni centar; 2000. (Serbian)
14. Benmansour S, Piotrowski JP, Altamirano AV, Frazer A. Impact of ovarian hormones on the modulation of the serotonin transporter by fluvoxamine. Neuropsychopharmacology 2009; 34(3): 555-64.
15. Simon GE, Fleck M, Lucas R, Bushnell DM; LIDO Group. Prevalence and predictors of depression treatment in an international primary care study. Am J Psychiatry 2004; 161(9): 1626-34.
16. Hamoda HM, Osser DN. The Psychopharmacology Algorithm Project at the Harvard South Shore Program: an update on psychotic depression. Harv Rev Psychiatry 2008; 16(4): 235-47.
17. Moret C. Combination/augmentation strategies for improving the treatment of depression. Neuropsychiatr Dis Treat 2005; 1(4): 301-9.